Skip to content
LFSTLifeStance Health Group, Inc.

Earnings

When LifeStance Health Group, Inc. reports, what it reported each quarter, and how the stock took the results.

25 quarters. Jun 30, 2020 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

Feb 23, after the close

Tue, Feb 23, 2027in 98 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Feb 22 – Mar 19

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$382.20M
Revenue, change from a year earlier: Q3 2026 +25.3%, Q2 2026 +26.1%, Q1 2026 +21.2%, Q4 2025 +17.4%
Net income
$11.67M
Net income, change from a year earlier: Q3 2026 +1,978.5%, Q2 2026 n/m, Q1 2026 +1,908.9%, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q3 2026$455.86M+25.3% vs Q3 2025

Latest results

  1. Q3 2026Nov 4, 2026, after the closeThe release5.6%by the close of Nov 5
    Revenue
    $455.86M
    +25.3%
    Net income
    $22.39M
    +1,978.5%
    EPS
    $0.06
    —
  2. Q2 2026Aug 5, 2026, after the closeThe release+2.9%by the close of Aug 6
    Revenue
    $435.35M
    +26.1%
    Net income
    $23.61M
    N/M
    EPS
    $0.06
    N/M
  3. Q1 2026May 6, 2026, after the closeThe release+19.6%by the close of May 7
    Revenue
    $403.48M
    +21.2%
    Net income
    $14.24M
    +1,908.9%
    EPS
    $0.04
    —
  4. Q4 2025Feb 24, 2026, after the closeThe release+4.3%by the close of Feb 25
    Revenue
    $382.20M
    +17.4%
    Net income
    $11.67M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 4, 2026 · after-hoursNov 5, 202636 d10-Q$455.86M+25.3%$0.065.6%
Q2 2026Jun 30, 2026Aug 5, 2026 · after-hoursAug 6, 202637 d10-Q$435.35M+26.1%$0.06+2.9%
Q1 2026Mar 31, 2026May 6, 2026 · after-hoursMay 7, 202637 d10-Q$403.48M+21.2%$0.04+19.6%
FY 2025
Q4 2025derivedDec 31, 2025Feb 24, 2026 · after-hoursFeb 25, 202656 d10-K$382.20M+17.4%—+4.3%
Q3 2025Sep 30, 2025Nov 5, 2025 · after-hoursNov 6, 202537 d10-Q$363.81M+16.3%$0.00+30.3%
Q2 2025Jun 30, 2025Aug 6, 2025 · after-hoursAug 7, 202538 d10-Q$345.31M+10.6%-$0.011.4%
Q1 2025Mar 31, 2025May 6, 2025 · after-hoursMay 7, 202537 d10-Q$332.97M+10.8%$0.0015.9%
FY 2024
Q4 2024derivedDec 31, 2024Feb 26, 2025 · after-hoursFeb 27, 202558 d10-K$325.48M+16.0%—+3.3%
Q3 2024Sep 30, 2024Nov 6, 2024 · after-hoursNov 7, 202438 d10-Q$312.72M+19.0%-$0.02+7.7%
Q2 2024Jun 30, 2024Aug 7, 2024 · after-hoursAug 8, 202439 d10-Q$312.33M+20.3%-$0.06—
Q1 2024Mar 31, 2024May 8, 2024 · after-hoursMay 9, 202439 d10-Q$300.44M+18.9%-$0.06+2.0%
Earlier years, FY 2020 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 5, 2026449746
10-QAug 6, 2026338107
10-QMay 7, 2026211814
10-KFeb 25, 2026071462
10-QNov 6, 2025269712
10-QAug 7, 2025105096
10-QMay 7, 2025065806
10-KFeb 27, 2025029100
10-QNov 7, 2024123376
10-QAug 8, 2024094105

Provenance

ProvenanceData status and checks

LifeStance Health Group, Inc. · CIK 1845257 · Engraved from SEC EDGAR